Back

GPS-estimated foot traffic data and venue selection for COVID-19 serosurveillance studies

Brown, T. S.; Martinez de Salazar Munoz, P.; Bhatia, A.; Bunda, B.; Williams, E. K.; Bor, D.; Miller, J. S.; Mohareb, A.; Naranbai, V.; Garcia Beltran, W.; Miller, T. E.; Thierauf, J.; Yang, W.; Kress, D.; Stelljes, K.; Johnson, K.; Larremore, D. B.; Lennerz, J.; Iafrate, A. J.; Balsari, S.; Buckee, C. O.; Grad, Y. H.

2021-02-05 epidemiology
10.1101/2021.02.03.21251011 medRxiv
Show abstract

The initial phase of the COVID-19 pandemic in the US was marked by limited diagnostic testing, resulting in the need for seroprevalence studies to estimate cumulative incidence and define epidemic dynamics. In lieu of systematic representational surveillance, venue-based sampling was often used to rapidly estimate a communitys seroprevalence. However, biases and uncertainty due to site selection and use of convenience samples are poorly understood. Using data from a SARS-CoV-2 serosurveillance study we performed in Somerville, Massachusetts, we found that the uncertainty in seroprevalence estimates depends on how well sampling intensity matches the known or expected geographic distribution of seropositive individuals in the study area. We use GPS-estimated foot traffic to measure and account for these sources of bias. Our results demonstrated that study-site selection informed by mobility patterns can markedly improve seroprevalence estimates. Such data should be used in the design and interpretation of venue-based serosurveillance studies.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.